This article is more than 5 years old. Information may no longer be current.

MacuHealth files lawsuit against Medop Health

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MacuHealth and its CEO, Frederic Jouhet, have filed a lawsuit against Medop Health, the manufacturer of MaxiVision Meso Plus Formula, citing false advertising and faulty manufacturing in relation to that product, according to a press release from MacuHealth.

The complaint alleges that there are “misleading representations of facts and characteristics ... to customers” in the MaxiVision Meso Plus Formula, “unfair competition” and a violation of the Consumer Protection Act, according to the release from MacuHealth.

Medop Health advertises that the product in question has a 10-10-2 formula (10 mg lutein, 10 mg mesozeaxanthin and 2 mg zeaxanthin), but MacuHealth claims that an independent analysis shows a lesser concentration, and that after a few months further deterioration was seen, according to the MacuHealth press release.

MacuHealth is being represented by Glenn Forbis of Harness Dickey & Pierce PLC, of Michigan.